Szymon Gnitecki

Szymon Gnitecki

Auto-generated profile, based on publicly available information

Szymon Gnitecki

Provincial Multi-Specialist Center of Oncology and Traumatology M. Copernicus in Łódź, ul. Pabianicka 62, 93-513 Łódź, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2024 in Biomedicines
Verified
Journal Article
Open access
KBKrzysztof Józef Badura
Krzysztof Józef Badura
JJJędrzej Janc
Jędrzej Janc
JWJoanna Wąsik
Joanna Wąsik
SGSzymon Gnitecki
Szymon Gnitecki
SSSylwia Skwira
Sylwia Skwira
BFBeata Franczyk
Beata Franczyk
Anemia is one of the most common chronic kidney disease (CKD) complications. It negatively affects patients’ quality of life and clinical outcomes. The pathophysiology of anemia in CKD involves the interplay of various factors such as erythropoietin (EPO) deficiency, iron dysregulation, chronic inflammation, bone marrow dysfunction, and nutritional deficiencies. Despite recent advances in understanding this condition, anemia still remains a serious clinical challenge in population of patients with CKD. Several guidelines have been published with the aim to systematize the diagnostic approach and treatment of anemia; however, due to emerging data, many recommendations vary between publications. Recent studies indicate a potential of novel biomarkers to evaluate anemia and related conditions such as iron deficiency, which is often present in CKD patients. Our article aims to summarize the pathophysiology of anemia in CKD, as well as the diagnosis and management of this condition, including novel therapeutic approaches such as hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHI). Understanding these complex subjects is crucial for a targeted approach to diagnose and treat patients with anemia in CKD effectively.

11 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JWJakub Wasiak
Jakub Wasiak
KZKacper Zielonka
Kacper Zielonka
BDBartosz Dądela
Bartosz Dądela
MMMarcin Markowski
Marcin Markowski
NŚNatalia Śliwa
Natalia Śliwa
MBMaciej Borowski
Maciej Borowski
Microbiota, a composition of trillions of microorganisms, plays essential roles in metabolism, immunity, and gut-brain axis connection. It helps in the digestion and production of valuable metabolites and keeps intestinal integrity intact. A balanced microbiota or eubiosis supports health; dysbiosis causes leaky gut syndrome, systemic inflammation, and chronic diseases. Therefore, the purpose of this review is to provide an analysis of the microbiota-gut-brain axis (GBA), as well as important microbial metabolites like trimethylamine N-oxide (TMAO), short chain fatty acids (SCFAs), and their implications concerning health and disease states. A comprehensive search of references related to microbiota was conducted on PubMed using the following search terms: “microbiota, gut-brain axis, dysbiosis, eubiosis, microbiota composition, microbial metabolites”. Major metabolites such as SCFAs help with the regulation of immune functions, act as protectors of the blood-brain barrier, and are known to support neuroprotection, while deleterious substances such as TMAO find association with cardiovascular diseases.Dysbiosis in the gut finds association with various chronic diseases such as type 2 diabetes, hypertension, and neurodegenerative disorders. Changes in microbial composition disrupt metabolic processes and provoke systemic inflammation. A better understanding of these mechanisms would facilitate the early detection of diseases based on the recognition of specific bacterial shifts and/or metabolite imbalances. Microbiota-health-improving relationships are still being explored, demonstrating the need for additional studies aimed at developments of specific treatments for disease prevention and treatment.

27 June 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NŚNatalia Śliwa
Natalia Śliwa
BDBartosz Dądela
Bartosz Dądela
EKEliza Kawalska
Eliza Kawalska
EMEmilia Majewska
Emilia Majewska
SGSzymon Gnitecki
Szymon Gnitecki
JJJoanna Jasińska
Joanna Jasińska
Statins are essential in preventing cardiovascular diseases by lowering LDL cholesterol levels. Landmark trials like 4S and HPS demonstrated significant reductions in cardiovascular events and mortality with statin use. Statins inhibit hepatic cholesterol synthesis and upregulate LDL receptors, improving endothelial function and exerting anti-inflammatory effects. However, adverse effects can lead to discontinuation. Musculoskeletal symptoms, including myalgia and rhabdomyolysis, affect 5-20% of patients, often linked to mitochondrial dysfunction and coenzyme Q10 depletion. Hepatotoxicity, although less frequent, presents as elevated transaminases, particularly with lipophilic statins. Statins may also increase new-onset diabetes risk by 9-12%, potentially due to impaired insulin signaling and mitochondrial dysfunction. Cognitive effects remain controversial, with some reports of memory impairment, especially with lipophilic statins. Managing statin intolerance involves dose reduction, switching to hydrophilic statins, or coenzyme Q10 supplementation. Alternative therapies for statin-intolerant patients include ezetimibe, PCSK9 inhibitors, and bempedoic acid. Lifestyle interventions like a Mediterranean diet and regular exercise further support cardiovascular health while minimizing adverse effects.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
SGSzymon Gnitecki
Szymon Gnitecki
JWJakub Wasiak
Jakub Wasiak
KZKacper Zielonka
Kacper Zielonka
BDBartosz Dądela
Bartosz Dądela
MMMarcin Markowski
Marcin Markowski
MBMaciej Borowski
Maciej Borowski
Mental disorders such as depression, bipolar disorder, schizophrenia, and anxiety are difficult to treat due to their complex neurobiological substrates. Traditional treatments, including pharmacotherapy and psychotherapy, are poor in alleviating symptoms in the majority of patients, where other forms of intervention have been sought. Creatine supplementation, which has been shown to previously improve sports performance, has been looked upon in this context as a form of treatment. Creatine plays a critical role in cellular energy metabolism, particularly in the brain, where it may be useful in the alleviation of energy deficits, oxidative stress, and mitochondrial dysfunction. This review consolidates available information on mechanisms of creatine action, clinical trials, and therapeutic implications in psychiatric disorders and discusses its well-established application in sports with its physiological and molecular effects. Specifically, we address creatine's influence on energy metabolism, neuroprotection, neurotransmitter modulation, and synaptic plasticity. The evidence shows creatine to be a potentially valuable adjunctive treatment, particularly in depression and affective disorders; however, more research is called for to elucidate its whole therapeutic value and develop optimal dosing regimens in heterogeneous patient populations.

10 April 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KZKacper Zielonka
Kacper Zielonka
JJJoanna Jasińska
Joanna Jasińska
BDBartosz Dądela
Bartosz Dądela
MMMarcin Markowski
Marcin Markowski
NŚNatalia Śliwa
Natalia Śliwa
MBMaciej Borowski
Maciej Borowski
Obstructive sleep apnea (OSA) is a common sleep disorder involving repeated upper airway obstructions during sleep, leading to hypoxia, fragmented sleep, and excessive daytime sleepiness. It is linked to significant cardiovascular and metabolic risks and affects 17-30% of individuals aged 30-69, with higher rates in the elderly. Diagnosis is typically made using polysomnography, which assesses the frequency and severity of apneic events. Treatment mainly involves continuous positive airway pressure (CPAP), although adherence can be challenging. Alternative therapies like oral appliances, positional therapy, and lifestyle modifications are helpful for milder cases. Medications such as GLP-1 receptor agonists, acetazolamide and 5-HT regulating have shown promise in reducing symptoms and improving CPAP compliance. Surgical options, such as uvulopalatopharyngoplasty (UPPP), maxillomandibular advancement (MMA), transoral robotic surgery (TORS) and tracheostomy, are considered when other treatments fail, particularly in patients with anatomical issues. Bariatric surgery can also reduce OSA severity in severely obese patients. Emerging therapies like hypoglossal nerve stimulation (HGNS), orofacial myofunctional therapy (OMT), and cognitive behavioral therapy for insomnia (CBT-I) offer solutions for patients who cannot tolerate CPAP. Advancements in AI and telemedicine are improving diagnosis and treatment personalization. OSA treatment requires a tailored approach, considering individual factors and comorbidities. Continued research is essential to optimize long-term care.

11 April 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
BDBartosz Dądela
Bartosz Dądela
SGSzymon Gnitecki
Szymon Gnitecki
JJJoanna Jasińska
Joanna Jasińska
SJSzymon Janczura
Szymon Janczura
EMEmilia Majewska
Emilia Majewska
MBMaciej Borowski
Maciej Borowski
Regular physical activity plays a key role in managing type 1 (T1D) and type 2 diabetes (T2D), improving insulin sensitivity, glycemic control, and metabolic health. Exercise helps maintain a healthy body weight, reduces the risk of cardiovascular diseases, and enhances mental well-being. For individuals with T2D, physical activity decreases insulin resistance, while for those with T1D, it increases the risk of hypoglycemia, requiring adjustments in insulin doses and carbohydrate intake. Continuous glucose monitoring (CGM) systems facilitate the detection of hypoglycemia, especially at night. A combination of aerobic and resistance training is recommended for optimal glycemic control and HbA1c reduction. In individuals at risk of T2D, such as those with prediabetes, regular exercise can delay or prevent disease onset. Tailored exercise programs and education on glucose management are essential for safe and effective implementation. Future research should focus on individualized exercise plans and long-term effects of physical activity on diabetes progression and complications. In conclusion, integrating regular physical activity into diabetes management significantly improves health outcomes and quality of life for patients with T1D and T2D, though challenges like hypoglycemia must be carefully managed.